Global Patent Index - EP 1100532 A2

EP 1100532 A2 2001-05-23 - METHODS OF USING LANREOTIDE, A SOMATOSTATIN ANALOGUE

Title (en)

METHODS OF USING LANREOTIDE, A SOMATOSTATIN ANALOGUE

Title (de)

ANWENDUNGSVERFAHREN FÜR LANREOTID, EIN SOMATOSTATIN ANALOGON

Title (fr)

PROCEDES D'UTILISATION D'UN ANALOGUE DE SOMATOSTATINE

Publication

EP 1100532 A2 (EN)

Application

EP 99937658 A

Priority

  • US 9917294 W
  • US 12652598 A
  • US 9469398 P

Abstract (en)

[origin: WO0006185A2] The present invention is directed to a method of treating one or more of the following disease and/or conditions, which comprises administering to a patient in need thereof the compound H-g(b)-D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2, where the Cysteines are bonded by a disulfide bond, or a pharmaceutically acceptable salt thereof, most preferably the acetate salt of the compound, in the treatment of certain diseases and/or conditions such as gastroenterological conditions and/or diseases, endocronological diseases and/or conditions, various types of cancers and conditions associated with cancer such as cancer cachexia and in the treatment of hypotension and panic attacks.

IPC 1-7 (main, further and additional classification)

A61K 38/31; A61P 1/04; A61P 1/12; A61P 1/14; A61P 1/18; A61P 3/08; A61P 5/02; A61P 5/08; A61P 5/18; A61P 5/48; A61P 9/02; A61P 9/10; A61P 9/12; A61P 17/02; A61P 17/06; A61P 19/08; A61P 25/18; A61P 35/00; A61P 43/00

IPC 8 full level (invention and additional information)

A61K 38/22 (2006.01); A61K 38/31 (2006.01); A61P 1/00 (2006.01); A61P 3/00 (2006.01); A61P 3/10 (2006.01); A61P 3/14 (2006.01); A61P 5/18 (2006.01); A61P 9/00 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 25/22 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01); C07K 14/655 (2006.01)

CPC (invention and additional information)

A61K 38/31 (2013.01)

Citation (search report)

See references of WO 0006185A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 0006185 A2 20000210; WO 0006185 A3 20000803; AR 023633 A1 20020904; AU 2004201783 A1 20040527; AU 5244799 A 20000221; AU 770193 B2 20040212; BR 9912609 A 20010502; CA 2335654 A1 20000210; CN 1334742 A 20020206; CZ 20010157 A3 20020213; EP 1100532 A2 20010523; HU 0102839 A2 20020128; HU 0102839 A3 20020228; IL 140837 D0 20020210; IL 181349 D0 20070704; JP 2002521456 A 20020716; MX PA01000969 A 20030407; NO 20010481 A 20010321; NO 20010481 D0 20010129; NO 324123 B1 20070827; NZ 509348 A 20040227; PL 346361 A1 20020211

INPADOC legal status


2008-03-07 [REG HK WD] APPLICATIONS WITHDRAWN, DEEMED TO BE WITHDRAWN, OR REFUSED AFTER PUBLICATION IN HONG KONG

- Document: HK 1035484

2004-05-12 [18W] WITHDRAWN

- Effective date: 20040309

2001-08-08 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20010625

2001-05-23 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010112

2001-05-23 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

2001-05-23 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO

- Free text: AL;LT;LV;MK;RO;SI